{'fraction_non_alphanumeric': 0.02330599913681485, 'fraction_numerical': 0.007768666378938282, 'mean_word_length': 5.036458333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Costs of disorders of the brain in Europe

Sir , The 13 reports under the title of Costs of Disorders of the Brain in Europe [1] in the supplement issue of the European Journal of Neurology present a first estimate of the cost of brain disorders in 25 countries of the European Union plus Iceland, Norway and Switzerland. These studies, without doubt, will stimulate discussion and efforts to improve the situation in the future. By recognition and awareness of the costs of disorders and their distribution, the neurologists, neurosurgeons and psychiatrists as well as others in health care will focus on the most prevalent disorders and research in these areas. This may result in using the existing sources efficiently and reducing the cost of brain disorders in the society. As an example, it is disclosed that drugs for brain disorders account for only 8% of total drug sales contrasting with relatively high and absolute costs of brain disorders. The authors estimated that 127 million people currently suffer from one or more brain disorders in a population of 466 million. Hence, all the authors who participated in these 13 studies deserve to be congratulated. However, there are many European countries with large populations not included in this study, such as Turkey, Albania, Croatia, Bosnia-Herzegovina, Serbia and Montenegro, Bulgaria, Romania, Ukraine, Moldova, Belarus and Russia. Despite this, the term Europe has been used in all titles of the articles. The authors state that data are very scarce for these additional populations. In fact, statistics on the different aspects of health care and costs exist in Turkey. These data can be easily obtained for research purposes when necessary from different institutions such as: Ministry of Health, Turkish Medical Association, universities and hospitals [5]. We would also like to draw your attention to the Turkish prevalence-based studies in some brain disorders in medical literature [2–4,6]. Furthermore, Turkey which is a member society of EFNS (European Federation of Neurological Societies) is not shown in the maps of Europe drawn in the supplement of European Journal of Neurology. Despite these deficiencies, We would like to thank the editorial board of the European Journal of Neurology for publishing this unique and beneficial project.